======= HK2 ======= == Gene Information == * **Official Symbol**: HK2 * **Official Name**: hexokinase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3099|3099]] * **UniProt**: [[https://www.uniprot.org/uniprot/P52789|P52789]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601125|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Hexokinase 2| |Hexokinase 1| |hexokinase activity| |mannokinase activity| |glucokinase activity| |maintenance of protein location in mitochondrion| |fructokinase activity| |negative regulation of mitochondrial membrane permeability| |negative regulation of membrane permeability| |glucose binding| |positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization| |regulation of autophagy of mitochondrion in response to mitochondrial depolarization| |positive regulation of autophagy of mitochondrion| |response to mitochondrial depolarisation| |glucose 6-phosphate metabolic process| |carbohydrate phosphorylation| |glucose catabolic process to pyruvate| |canonical glycolysis| |NADH regeneration| |glycolytic process through fructose-6-phosphate| |glycolytic process through glucose-6-phosphate| |glucose catabolic process| |NADH metabolic process| |maintenance of protein localization in organelle| |glycolytic process| |regulation of autophagy of mitochondrion| |ATP generation from ADP| |sarcoplasmic reticulum| |lactation| |NAD metabolic process| |response to ischemia| |ADP metabolic process| |hexose catabolic process| |negative regulation of reactive oxygen species metabolic process| |regulation of glucose import| |apoptotic mitochondrial changes| |nucleoside diphosphate phosphorylation| |purine nucleoside diphosphate metabolic process| |monosaccharide catabolic process| |nucleotide phosphorylation| |purine ribonucleoside diphosphate metabolic process| |ribonucleoside diphosphate metabolic process| |establishment of protein localization to mitochondrion| |pyruvate metabolic process| |regulation of mitochondrial membrane permeability| |regulation of glucose transmembrane transport| |body fluid secretion| |maintenance of protein location in cell| |protein localization to mitochondrion| |regulation of membrane permeability| |nucleoside diphosphate metabolic process| |cellular glucose homeostasis| |maintenance of location in cell| |cellular response to leukemia inhibitory factor| |response to leukemia inhibitory factor| |maintenance of protein location| |glucose metabolic process| |positive regulation of mitochondrion organization| |carbohydrate catabolic process| |positive regulation of autophagy| |mitochondrial membrane organization| |mammary gland development| |hexose metabolic process| |mitochondrial outer membrane| |maintenance of location| |positive regulation of angiogenesis| |cellular carbohydrate metabolic process| |regulation of reactive oxygen species metabolic process| |regulation of mitochondrion organization| |positive regulation of vasculature development| |glucose homeostasis| |carbohydrate homeostasis| |monosaccharide metabolic process| |ATP metabolic process| |mitochondrial transport| |regulation of angiogenesis| |purine ribonucleotide metabolic process| |regulation of vasculature development| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |regulation of autophagy| |ribose phosphate metabolic process| |response to hypoxia| |response to decreased oxygen levels| |positive regulation of cellular catabolic process| |purine-containing compound metabolic process| |response to oxygen levels| |gland development| |generation of precursor metabolites and energy| |positive regulation of catabolic process| |establishment of protein localization to organelle| |small molecule catabolic process| |mitochondrion organization| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |carbohydrate metabolic process| |regulation of body fluid levels| |monocarboxylic acid metabolic process| |nucleobase-containing small molecule metabolic process| |regulation of transmembrane transport| |positive regulation of organelle organization| |protein localization to organelle| |cellular chemical homeostasis| |regulation of cellular catabolic process| |membrane organization| |organophosphate metabolic process| |cellular homeostasis| |carboxylic acid metabolic process| |apoptotic process| |oxidation-reduction process| |regulation of catabolic process| |oxoacid metabolic process| |cellular response to cytokine stimulus| |organic acid metabolic process| |carbohydrate derivative metabolic process| |programmed cell death| |regulation of anatomical structure morphogenesis| |cell death| |response to cytokine| |chemical homeostasis| |secretion| |response to abiotic stimulus| |positive regulation of cellular component organization| |phosphorylation| |regulation of organelle organization| |positive regulation of developmental process| |ATP binding| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |homeostatic process| |cellular response to stress| |positive regulation of multicellular organismal process| |small molecule metabolic process| |organic substance catabolic process| |regulation of transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp34|Rotenone 20μM R00 exp34]]|-2.18| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.71| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|1.71| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.72| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|1.73| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.75| |[[:results:exp360|Genistein 15μM R07 exp360]]|1.76| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.78| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.79| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.81| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|1.83| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.86| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.86| |[[:results:exp436|Dynasore 7μM R08 exp436]]|1.91| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|1.91| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|1.94| |[[:results:exp336|Asunaprenir 3μM R07 exp336]]|1.97| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.97| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|1.99| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|2| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.01| |[[:results:exp135|MS023 7μM R03 exp135]]|2.02| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.03| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|2.06| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|2.08| |[[:results:exp302|35°C R06 exp302]]|2.23| |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|2.23| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.26| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|2.33| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.51| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|2.54| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|2.64| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|2.66| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.67| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.71| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|2.75| |[[:results:exp264|Arsenate 40μM R06 exp264]]|3.01| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|3.41| |[[:results:exp79|Q15 2.7μM R02 exp79]]|4.31| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|6.4| ^Gene^Correlation^ |[[:human genes:p:pfkp|PFKP]]|0.709| |[[:human genes:g:gpi|GPI]]|0.624| |[[:human genes:s:slc2a1|SLC2A1]]|0.564| |[[:human genes:p:pgls|PGLS]]|0.562| |[[:human genes:p:pgp|PGP]]|0.553| |[[:human genes:h:hk1|HK1]]|0.484| |[[:human genes:v:vdac1|VDAC1]]|0.426| |[[:human genes:a:ahcyl1|AHCYL1]]|0.415| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 315 * **Expression level (log2 read counts)**: 7.26 {{:chemogenomics:nalm6 dist.png?nolink |}}